These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11060248)

  • 1. [Inflammation, infection and coronary artery disease: myths and realities. Special XXXV Conference of the National Congress of the Spanish Society of Cardiology].
    Kaski JC
    Rev Esp Cardiol; 2000 Oct; 53(10):1311-7. PubMed ID: 11060248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of inflammation and infection in acute coronary syndrome].
    Blankenberg S; Rupprecht HJ; Bickel C; Hafner G; Meyer J
    Herz; 2001 Apr; 26 Suppl 1():9-18. PubMed ID: 11349630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlamydia pneumoniae and coronary artery disease: the antibiotic trials.
    Higgins JP
    Mayo Clin Proc; 2003 Mar; 78(3):321-32. PubMed ID: 12630585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic therapy for treatment of Chlamydia to prevent coronary heart disease events.
    Muhlestein JB
    Curr Atheroscler Rep; 2000 Jul; 2(4):336-41. PubMed ID: 11122763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotics for secondary prevention of coronary artery disease: an ACES hypothesis but we need to PROVE IT.
    Gelfand EV; Cannon CP
    Am Heart J; 2004 Feb; 147(2):202-9. PubMed ID: 14760314
    [No Abstract]   [Full Text] [Related]  

  • 6. Inflammation, infection and antimicrobial therapy in coronary heart disease--where do we currently stand?
    Ngeh J; Gupta S
    Fundam Clin Pharmacol; 2001 Apr; 15(2):85-93. PubMed ID: 11468018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chlamydia pneumoniae, atherosclerosis, and coronary disease].
    Monno R; Di Biase M; Costi A; de Nicolò T; Correale M; Bolognese P; Losacco G
    Ital Heart J Suppl; 2003 May; 4(5):383-97. PubMed ID: 12848076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlamydia pneumoniae and atherosclerosis: does the evidence support a causal or contributory role?
    Mahony JB; Coombes BK
    FEMS Microbiol Lett; 2001 Apr; 197(1):1-9. PubMed ID: 11287138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of evidence for a connection between Chlamydia pneumoniae and atherosclerotic disease.
    Dugan JP; Feuge RR; Burgess DS
    Clin Ther; 2002 May; 24(5):719-35. PubMed ID: 12075941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease.
    Mehta JL; Saldeen TG; Rand K
    J Am Coll Cardiol; 1998 May; 31(6):1217-25. PubMed ID: 9581711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathologic signs for the inflammatory role of Chlamydia pneumoniae in the high-grade atherosclerotic coronary artery wall.
    Legan M; Vraspir-Porenta O; Kese D; Zorc-Pleskovic R; Zorc M
    Angiology; 2004; 55(5):525-31. PubMed ID: 15378115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of infection in atherosclerosis and coronary artery disease: a new therapeutic target.
    Ismail A; Khosravi H; Olson H
    Heart Dis; 1999; 1(4):233-40. PubMed ID: 11720630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic therapy for coronary heart disease: the myth and the reality.
    Kuppuswamy VC; Gupta S
    Timely Top Med Cardiovasc Dis; 2006 Jan; 10():E2. PubMed ID: 16404482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlamydia pneumoniae and atherosclerosis: from Koch postulates to clinical trials.
    Liu C; Waters DD
    Prog Cardiovasc Dis; 2005; 47(4):230-9. PubMed ID: 15991152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infectious atherosclerosis: is the hypothesis still alive? A clinically based approach to the dilemma.
    Alviar CL; Echeverri JG; Jaramillo NI; Figueroa CJ; Cordova JP; Korniyenko A; Suh J; Paniz-Mondolfi A
    Med Hypotheses; 2011 Apr; 76(4):517-21. PubMed ID: 21216537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Chlamydia pneumoniae in atherosclerosis.
    Watson C; Alp NJ
    Clin Sci (Lond); 2008 Apr; 114(8):509-31. PubMed ID: 18336368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of infection in atherosclerosis and coronary artery disease: a new therapeutic target?
    Frishman WH; Ismail AA
    Cardiol Rev; 2002; 10(4):199-210. PubMed ID: 12144730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on the correlation of between infection, inflammation and coronary artery disease].
    Cai XJ; Cai HB; Lu D
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jun; 24(6):503-7. PubMed ID: 12848920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging concepts in disease management: a role for antimicrobial therapy in coronary artery disease.
    Girard SE; Temesgen Z
    Expert Opin Pharmacother; 2001 May; 2(5):765-72. PubMed ID: 11336621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infection and atherosclerosis. An alternative view on an outdated hypothesis.
    Stassen FR; Vainas T; Bruggeman CA
    Pharmacol Rep; 2008; 60(1):85-92. PubMed ID: 18276989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.